Unfortunately, patients with TP53-mutated AML show minimal benefit from modern treatments, including venetoclax/azacytidine combinations, with overall survival of only 5.52 months
However, these products are regulated as food supplements in the UK, not medicines, and have not undergone the rigorous testing required for licensed ED treatments
Nakanishi G, Pita-Oliveira M, Bertagnolli LS, Torres-Loureiro S, Scudeler MM, Cirino HS, et al
Many participants in the trials achieved excellent results at 8 mg without needing to escalate to the 12 mg maximum, which suggests that the highest dose is not necessary or appropriate for everyone
For scalp hair, well-formulated topical application, especially paired with microneedling, is the evidence-supported approach